Research and Development

Showing 15 posts of 9603 posts found.

AstraZeneca looks for new partners to bolster pipeline

January 16, 2012 Business Services, Research and Development, Sales and Marketing AstraZeneca, BMS

AstraZeneca has used a recent healthcare conference in San Francisco to call for new drug development partners. Speaking at the …

Novartis to cut 2,000 US jobs

January 13, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diovan, Novartis, job cuts

Novartis will slash 1,960 jobs in the US as it prepares for life without its blockbuster medicine Diovan. The hypertension …

Pharma unprepared for annus horribilis

January 12, 2012 Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma

A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …

Merck facility reborn as science park

January 11, 2012 Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland

A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …

Crisis in the boardroom: 2011’s most dramatic departures

January 11, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, KV pharmaceuticals, Kindler, Pfizer, management

In December 2010, Jeffrey Kindler, the chief executive of Pfizer suddenly announced his departure from the company.His abrupt exit made …

Janssen signs deal with rising star Forma

January 11, 2012 Research and Development Forma, Janssen, alliance

Janssen has signed a deal with Forma Therapeutics to discover, and develop drugs that target tumour metabolism mechanisms.Forma focuses on …

Richard Barker joins Aegate as a senior advisor

January 11, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aegate, Richard Barker

Aegate’s board of directors have announced that the previous director general of the ABPI has joined the company as a …
Sanofi picture

Sanofi to collaborate with UCSF on diabetes research

January 11, 2012 Research and Development RNA interference, Sanofi, UCSF, academic alliance, diabetes

The University of California, San Francisco (UCSF) and Sanofi are to launch a new collaboration in diabetes research, focusing on …

Underwhelming results for GSK’s Relovair

January 10, 2012 Research and Development, Sales and Marketing Advair, COPD, GSK, Relovair, Seretide, asthma

GlaxoSmithKline says it is on track to file its respiratory drug Relovair in Europe and the US despite mixed results …

Shire signs strategic partnership deal with ICON

January 10, 2012 Research and Development ICON, Shire

Contract research organisation ICON has signed a strategic partnership with Shire Specialty Pharmaceuticals to be the sole global provider of …

Study supports GLP-1 agonists for weight loss

January 10, 2012 Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Sanofi, diabetes, lilly

An independent study by academics has concluded that GLP-1 agonist drugs help patients to lose weight – with the effect …

BMS to buy hep C firm Inhibitex for $2.5 billion

January 9, 2012 Research and Development, Sales and Marketing BMS, Inhibitex, hep C

Bristol-Myers Squibb will acquire virology specialist Inhibitex for $2.5 billion, expanding its infectious disease portfolio. Bristol-Myers Squibb will acquire the …

Celgene appoints Dr David Gillen as its UK and Ireland medical director

January 9, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Celgene

Celgene has appointed former Pfizer man Dr David Gillen as its new UK and Ireland medical director. Gillen brings much …
Merkel and Sarkozy

2011 Year In Review

January 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing 2011, Europe, emerging markets, year in review

A round up of some of the key themes in pharma’s yearEUROPE IN CRISIS While the Eurozone has averted meltdown …

New requirements for the technical validations of Marketing Authorisation Applications

January 6, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The current EU- eCTD v3.1 validation criteria came into force on 1st September 2011 for the technical validation for all …
The Gateway to Local Adoption Series

Latest content